Cancer

Items 91-100 of 156

per page
Set Descending Direction
  1. CD40 (human):Fc (human) (rec.)
    AG-40B-0083
    AG-40B-0083-C05050 µg
    CHF 300.00
    AG-40B-0083-30503 x 50 µg
    CHF 600.00
  2. CD80 (mouse):Fc (mouse) (rec.)
    CHI-MF-110CD80
    CHI-MF-110CD80-C100100 µg
    CHF 430.00
  3. CD86 (mouse):Fc (mouse) (rec.)
    CHI-MF-110CD86
    CHI-MF-110CD86-C100100 µg
    CHF 430.00
  4. Clusterin (nuclear form) (mouse) (rec.) (His)
    AG-40A-0057
    AG-40A-0057-C05050 µg
    CHF 380.00
  5. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  6. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)
  7. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  8. DR6 (mouse):Fc (human) (rec.)
    AG-40B-0062
    AG-40B-0062-C05050 µg
    CHF 170.00
    AG-40B-0062-30503 x 50 µg
    CHF 335.00
  9. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  10. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.

Items 91-100 of 156

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.